As CEO, U.S. and President, North America, Nathalie leads the North America Region for Haleon, one of the largest Consumer Health companies in the world. In this role, she is responsible for overseeing the business unit, inclusive of brand management, customer and expert sales, innovation, and operations. Under her leadership, the team builds superior brands such as Advil, Centrum, Emergen-C, Flonase, parodontax, Sensodyne, Theraflu and TUMS for our consumers, while ensuring we continue to deliver better everyday health with humanity. Nathalie is also a member of the Haleon Executive Team, responsible for representing the region at the leadership level.

She joined the company in 2025, after 23 years at L’Oreal, most recently as President, Consumer Product Division, North America. Prior to this, Nathalie held roles of increasing responsibility in marketing and general management across brands like Garnier, Maybelline and Essie, in several markets, including Europe, Asia and the U.S.

Nathalie earned a degree in International Management from HEC Paris and an MBA from London Business School. She has also served terms on the Board of Directors for publicly held companies.